AI in Healthcare

Two patients died in a Phase 2 autoimmune cell therapy trial — but not from the treatment itself. Still, Artiva Therapeutics shut down. This isn’t about data. It’s about perception. In AI-driven healthcare, where models must learn from real-world outcomes, how do we distinguish signal from noise when human lives are at stake? The collapse of a promising therapy after two unrelated deaths reveals a deeper truth: clinical risk is not just medical — it’s psychological, financial, and systemic. This story, from STAT News, shows how one event can end a company, even when science exonerates the drug. https://www.statnews.com/2026/10/27/autoimmune-cell-therapy-trial-artiva-therapeutics-shutting-down/ Source: https://www.statnews.com/2026/10/27/autoimmune-cell-therapy-trial-artiva-therapeutics-shutting-down/ View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.